Are statins safe in patients with COVID-19?

Karalis, Dean G

Karalis, Dean G.

Karalis DG; Division of Cardiology, Thomas Jefferson University Hospital, Philadelphia, PA, USA. Electronic address: Dean.Karalis@jefferson.edu.

J Clin Lipidol ; 14(4): 396-397, 2020.

Article in English | MEDLINE | ID: covidwho-610629

Subject(s)

Betacoronavirus; Coronavirus Infections/blood; Coronavirus Infections/drug therapy; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Pneumonia, Viral/blood; Pneumonia, Viral/drug therapy; COVID-19; Humans; Observational Studies as Topic/methods; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Betacoronavirus Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: J Clin Lipidol Journal subject: Biochemistry / Metabolism Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google